BCL2 and neuroblastoma: These data also revealed that some neuroblastoma cells were sensitive to multiple BH3-mimetics (SJNB-12, Lan-5 and CHLA-15) and hence depend on different antiapoptotic BCL-2 proteins for survival, whereas others only responded to one selective BH3-mimetic (IMR-32, CHP-212 and Kelly).